title: The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Sawka
authors.forename: Heather
authors.initials: H
authors.lastname: Rilkoff
authors.forename: Richard W
authors.initials: RW
authors.lastname: Tsang
authors.forename: James D
authors.initials: JD
authors.lastname: Brierley
authors.forename: Lorne
authors.initials: L
authors.lastname: Rotstein
authors.forename: Shereen
authors.initials: S
authors.lastname: Ezzat
authors.forename: Sylvia L
authors.initials: SL
authors.lastname: Asa
authors.forename: Phillip
authors.initials: P
authors.lastname: Segal
authors.forename: Catherine
authors.initials: C
authors.lastname: Kelly
authors.forename: Afshan
authors.initials: A
authors.lastname: Zahedi
authors.forename: Amiram
authors.initials: A
authors.lastname: Gafni
authors.forename: David P
authors.initials: DP
authors.lastname: Goldstein
mesh_terms: D002277:Carcinoma / Q000532:radiotherapy* / Q000601:surgery; D002291:Carcinoma, Papillary; D003658:Decision Making, Computer-Assisted; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant; D000077273:Thyroid Cancer, Papillary; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D013965:Thyroidectomy
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals